Advertisement
Advertisement
CLDI
Calidi Biotherapeutics, Inc.
0.68
USDSponsored
-0.05
-6.70%
Nov 10, 15:54 UTC -5
Closed
After-Market
0.71
+0.02
+3.65%
Calidi Biotherapeutics, Inc. (CLDI)
Calidi Biotherapeutics, Inc. Financial Snapshot
| Market Cap | 1.83M |
| Beta | 1.37 |
| Earnings Per Share (EPS) | -54.30 |
| Price-to-Book (P/B) Ratio | 0.49 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 29.62% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -368.29% |
| Current Ratio | 1.68% |
| Free Cash Flow | -8.51M |
